Quadrant Private Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Quadrant Private Wealth Management, LLC

  • $399 Million
  • Q3 2024

A detailed history of Quadrant Private Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Quadrant Private Wealth Management, LLC holds 8,641 shares of GILD stock, worth $793,935. This represents 0.18% of its overall portfolio holdings.

Number of Shares
8,641
Previous 8,742 1.16%
Holding current value
$793,935
Previous $599,000 20.87%
% of portfolio
0.18%
Previous 0.14%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$66.59 - $83.99 $6,725 - $8,482
-101 Reduced 1.16%
8,641 $724,000
Q2 2024

Aug 13, 2024
BUY
$63.15 - $72.88 $12,882 - $14,867
204 Added 2.39%
8,742 $599,000
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $17,823 - $21,735
-249 Reduced 2.83%
8,538 $625,000
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $23,373 - $26,505
-319 Reduced 3.5%
8,787 $711,000
Q3 2023

Nov 13, 2023
SELL
$73.94 - $80.67 $38,596 - $42,109
-522 Reduced 5.42%
9,106 $682,000
Q2 2023

Aug 11, 2023
SELL
$76.01 - $86.7 $15,202 - $17,340
-200 Reduced 2.04%
9,628 $742,000
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $16,157 - $18,408
-209 Reduced 2.08%
9,828 $815,000
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $56,835 - $81,596
-912 Reduced 8.33%
10,037 $861,000
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $28,455 - $32,049
-493 Reduced 4.31%
10,949 $677,000
Q1 2022

May 12, 2022
SELL
$57.92 - $72.58 $3,764 - $4,717
-65 Reduced 0.56%
11,442 $680,000
Q4 2021

Feb 08, 2022
SELL
$64.88 - $73.64 $28,741 - $32,622
-443 Reduced 3.71%
11,507 $836,000
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $13,538 - $14,606
-200 Reduced 1.65%
11,950 $835,000
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $44,365 - $48,475
-699 Reduced 5.44%
12,150 $837,000
Q1 2021

May 17, 2021
SELL
$60.0 - $68.46 $4,200 - $4,792
-70 Reduced 0.54%
12,849 $830,000
Q4 2020

Feb 12, 2021
SELL
$56.65 - $64.55 $34,046 - $38,794
-601 Reduced 4.45%
12,919 $753,000
Q3 2020

Nov 12, 2020
SELL
$62.1 - $78.08 $14,904 - $18,739
-240 Reduced 1.74%
13,520 $854,000
Q2 2020

Aug 04, 2020
BUY
$72.34 - $84.0 $190,037 - $220,668
2,627 Added 23.6%
13,760 $1.06 Million
Q1 2020

May 08, 2020
BUY
$62.63 - $80.22 $697,259 - $893,089
11,133 New
11,133 $832,000

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Quadrant Private Wealth Management, LLC Portfolio

Follow Quadrant Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Private Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email